PubMed Health⌕ Search

PubMed · 3502190

[A new parametric image using dynamic SPECT with inhaled 133Xe].

Abstract

As a new parametric image of cerebral lesions, a map of the ratio between regional cerebral blood flow (rCBF) and the 2nd image of a series of dynamic images was proposed and tested. Three classes (poor, mild and well) were defined based on the degree of coupling between the rCBF and the new parametric image of the affected lesion. In 16 patients with cerebral infarction, those in the acute stage (within 1 week after onset) were found to belong to the poor coupling group, and the subacute group (1 to 4 weeks) showed mild coupling. In the chronic group (over 4 weeks), well coupling was observed. All patients of TIA fell into the mild coupling group. In a stimulation study with 5% CO2 mixed air, all of the well or mild-coupled lesions changed to uncoupled. These clinical findings demonstrate the characteristics of the new proposed image.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

A Komatani, Y Sugai, K Yamaguchi. 1987. [A new parametric image using dynamic SPECT with inhaled 133Xe].. https://doi.org/10.3769/radioisotopes.36.11_587

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Concurrent carbogen and radiation therapy in children with high-risk brainstem gliomas.

In an attempt to improve local control, we assessed the feasibility of the addition of 4 min of carbogen inhalation (as a radiosensitizer) to daily fractionated radiotherapy in pediatric patients with high grade and/or diffuse brainstem gliomas. Ten patients inhaled carbogen for >90% of the radiation treatments. Median survival time from start of therapy was 0.80 years. Carbogen inhalation did not appear to improve the dismal prognosis.

Administration, Inhalation↗

2. Advances in pharmacotherapy for COPD.

Chronic obstructive pulmonary disease (COPD) is the most common chronic lung disease in the world. In 1999, COPD ranked sixth among the most common causes of death and twelfth as a worldwide burden of disease. It has been estimated that by the year 2020 COPD will be the third leading cause of death and fifth as a worldwide burden of disease. Thus, COPD is a major medical problem and there is evidence that it is increasing throughout the world. Despite recognition of COPD as an important international health problem, COPD has been neglected among common diseases, with little investment in research on its underlying cellular and molecular mechanisms. Recently, global and Japanese guidelines for COPD have been published. These guidelines seem to be useful to improve the underdiagnosis and undertreatment of COPD. In this review, I describe briefly the current recommendation for pharmacological therapy of stable COPD according to the global and Japanese guidelines for COPD.

Administration, Inhalation↗